IS THERE A ROLE FOR INCREASED PD-1 AND PD-1 LIGAND EXPRESSIONS AFTER SEPTIC SHOCK?

被引:0
|
作者
Guignant, Caroline
Venet, Fabienne
Lepape, Alain
Monneret, Guillaume
机构
[1] Hosp Civils Lyon, Immunol Lab, Lyon, France
[2] Hosp Civils Lyon, Intens Care Units, Lyon, France
来源
SHOCK | 2009年 / 32卷
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [41] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Wang, Rui-na
    Yu, Qian
    Wang, Xiao-bo
    Zhu, Di
    Li, Guo-long
    Li, Zeng-xia
    Jiang, Wei
    Li, Wei
    Dang, Yong-jun
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (10) : 2103 - 2112
  • [42] PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
    Xu-Monette, Zijun Y.
    Zhou, Jianfeng
    Young, Ken H.
    BLOOD, 2018, 131 (01) : 68 - 83
  • [43] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Rui-na Wang
    Qian Yu
    Xiao-bo Wang
    Di Zhu
    Guo-long Li
    Zeng-xia Li
    Wei Jiang
    Wei Li
    Yong-jun Dang
    Acta Pharmacologica Sinica, 2023, 44 : 2103 - 2112
  • [44] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [45] Programmed Death-1 (PD-1) Receptor/PD-1 Ligand (PD-L1) Expression in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Michal, Michal
    Hes, Ondrej
    LABORATORY INVESTIGATION, 2017, 97 : 211A - 211A
  • [46] PD-1/PD-1-ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
    Yamamoto, Ryo
    Nishikori, Momoko
    Kitawaki, Toshio
    Sakai, Tomomi
    Hishizawa, Masakatsti
    Tashima, Malsaharu
    Kondo, Tadakazu
    Ohmori, Katsuyuki
    Uchiyama, Takashi
    BLOOD, 2007, 110 (11) : 118A - 119A
  • [47] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Mundo, Enric Condom
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Dusek, Martin
    Hora, Milan
    Michal, Michal
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 : 17 - 22
  • [48] Sepsis in PD-1 light
    Monneret, Guillaume
    Gossez, Morgane
    Venet, Fabienne
    CRITICAL CARE, 2016, 20
  • [49] PD-1 takes control
    Houston, Stephanie
    NATURE IMMUNOLOGY, 2023, 24 (11) : 1781 - 1781
  • [50] Targeting of PD-1 in cancer
    Weber, J. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 312 - 312